Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2023-12-04 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
董事会薪酬与考核委员会工作细则 （2023年12月）
Governance Information Classification · 95% confidence The document is titled as the 'Work Rules of the Board Remuneration and Assessment Committee' of a company, detailing the committee's composition, responsibilities, decision-making procedures, and operational rules. It references relevant laws and governance codes but does not contain financial data, audit results, or report publication announcements. It is a governance-related document focusing on internal rules and committee procedures related to remuneration and assessment of directors and senior management. Therefore, it fits best under Governance Information (CGR). The document length is 2758 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2023-12-04 Chinese
独立董事专门会议工作制度（2023年12月）
Governance Information Classification · 95% confidence The document is titled as a working system for the Independent Directors' Special Meeting of a company, detailing governance procedures, meeting protocols, voting rights, and responsibilities of independent directors. It focuses on internal governance rules and board meeting procedures rather than financial data, earnings, or regulatory filings. There is no indication of financial results, audit reports, or announcements related to capital, dividends, or legal proceedings. The content aligns with governance practices and internal company rules. Therefore, the document fits best under Governance Information (CGR). The document length is short and does not indicate it is an announcement or a report publication notice, so it is not RPA or RNS.
2023-12-04 Chinese
董事会议事规则（2023年12月）
Governance Information Classification · 95% confidence The document is titled "华邦生命健康股份有限公司 董事会议事规则 (2023 年 12 月修订稿)" which translates to "Rules of Procedure for the Board of Directors of Huabang Life Health Co., Ltd. (December 2023 Revised Edition)". The content details the structure, responsibilities, powers, and procedures of the company's board of directors, including committees, meetings, voting, and independent directors' roles. It references relevant laws, regulations, and stock exchange rules but does not contain financial statements, audit opinions, or financial results. It is a governance document outlining internal rules and board structure rather than a report or announcement of financial or operational results. Therefore, it fits the category of Governance Information (CGR). The document length (7865 characters) and detailed procedural content support this classification with high confidence.
2023-12-04 Chinese
股东大会议事规则（2023年12月）
Governance Information Classification · 100% confidence The document is titled as the "Rules of Procedure for the Shareholders' General Meeting" of a company, detailing the procedures, rights, and responsibilities related to the convening, proposal submission, voting, and decision-making processes of shareholders' meetings. It extensively covers the governance and operational rules for shareholder meetings, including voting rights, proposal handling, meeting notices, and legal compliance. There is no financial data, earnings information, or audit content. It is not a report of results or an announcement of voting outcomes but a governance document outlining internal rules and procedures. Therefore, this document fits the category of Governance Information (CGR). The document length and detail further support it being a substantive governance report rather than a brief announcement or notice.
2023-12-04 Chinese
独立董事工作制度（2023年12月）
Governance Information Classification · 95% confidence The document is titled as an "Independent Director Work System" for a company, detailing the rules, qualifications, duties, nomination, election, and protections for independent directors. It is a governance-related document outlining internal rules and procedures for board members, specifically independent directors. There is no financial data, earnings information, or report publication mentioned. It is not an announcement or a brief summary but a detailed governance policy document. Therefore, it fits best under Governance Information (CGR).
2023-12-04 Chinese
关于召开2023年第一次临时股东大会的通知公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2023 first extraordinary general meeting of shareholders for 华邦生命健康股份有限公司. It includes information about the meeting date, voting procedures (both in-person and online), agenda items to be voted on, legal compliance, and instructions for shareholders. There is no financial data, earnings information, or audit content. The document is not a report itself but a formal announcement and invitation to the shareholders to attend and vote at the meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings.
2023-12-04 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.